Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 1
2015 1
2016 2
2017 1
2019 3
2020 3
2021 2
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Dose-escalation in prostate cancer: Results of randomized trials.
Kissel M, Krhili SL, Minsat M, El Ayachy R, Bringer S, Lahmi L, Porte J, Labib A, Graff P, Crehange G. Kissel M, et al. Among authors: krhili sl. Cancer Radiother. 2022 Oct;26(6-7):899-904. doi: 10.1016/j.canrad.2022.07.011. Epub 2022 Aug 24. Cancer Radiother. 2022. PMID: 36030191 Review.
[The role of proton therapy in esophageal cancer].
Créhange G, Goudjil F, Krhili SL, Minsat M, de Marzi L, Dendale R. Créhange G, et al. Among authors: krhili sl. Cancer Radiother. 2022 Jun;26(4):604-610. doi: 10.1016/j.canrad.2021.08.015. Epub 2021 Oct 20. Cancer Radiother. 2022. PMID: 34688549 Clinical Trial. French.
Immune gene expression in head and neck squamous cell carcinoma patients.
Lecerf C, Kamal M, Vacher S, Chemlali W, Schnitzler A, Morel C, Dubot C, Jeannot E, Meseure D, Klijanienko J, Mariani O, Borcoman E, Calugaru V, Badois N, Chilles A, Lesnik M, Krhili S, Choussy O, Hoffmann C, Piaggio E, Bieche I, Le Tourneau C. Lecerf C, et al. Among authors: krhili s. Eur J Cancer. 2019 Nov;121:210-223. doi: 10.1016/j.ejca.2019.08.028. Epub 2019 Oct 5. Eur J Cancer. 2019. PMID: 31593831
Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma.
Leblanc O, Vacher S, Lecerf C, Jeannot E, Klijanienko J, Berger F, Hoffmann C, Calugaru V, Badois N, Chilles A, Lesnik M, Krhili S, Bieche I, Le Tourneau C, Kamal M. Leblanc O, et al. Among authors: krhili s. Cancer Biol Med. 2020 Feb 15;17(1):208-217. doi: 10.20892/j.issn.2095-3941.2019.0153. Cancer Biol Med. 2020. PMID: 32296588 Free PMC article.
Curative high-dose reirradiation for patients with recurrent head and neck squamous cell carcinoma using IMRT or proton therapy: Outcomes and analysis of patterns of failure.
Beddok A, Saint-Martin C, Krhili S, Eddine CA, Champion L, Chilles A, Goudjil F, Zefkili S, Amessis M, Peurien D, Choussy O, le Tourneau C, Dendale R, Buvat I, Créhange G, Calugaru V. Beddok A, et al. Among authors: krhili s. Head Neck. 2022 Nov;44(11):2452-2464. doi: 10.1002/hed.27153. Epub 2022 Jul 25. Head Neck. 2022. PMID: 35875934 Free article.
Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity.
Beddok A, Maynadier X, Krhili S, Ala Eddine C, Champion L, Chilles A, Goudjil F, Zefkili S, Amessis M, Choussy O, Le Tourneau C, Buvat I, Créhange G, Carton M, Calugaru V. Beddok A, et al. Among authors: krhili s. Strahlenther Onkol. 2023 Oct;199(10):901-909. doi: 10.1007/s00066-023-02080-y. Epub 2023 May 31. Strahlenther Onkol. 2023. PMID: 37256301
18 results